ImmunoCellular announced that ICT-107, its dendritic cell-based vaccine, demonstrated a statistically significant increase in progression-free survival, or PFS, in patients with newly diagnosed ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈